InPlay Oil (IPO) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
13 Aug, 2026Strategic direction and growth
Focus on disciplined M&A and organic growth of high-return assets, targeting 10–14% CAGR in production and reserves per share over the past decade.
Conservative leverage maintained, with a long-term target of 0.75x net debt/EBITDA and current leverage at 1.2–1.3x.
Emphasis on maximizing shareholder returns, including a 7.2% dividend yield and 28% total return forecast for FY2025.
Strong free adjusted funds flow (FAFF) generation, with $62 million projected for FY2025 and $84 million for FY2026.
Asset base and acquisitions
Production of ~20,100 boe/d post-acquisition, with over 10,500 bbl/d oil, making it the largest Cardium oil producer.
Recent Belly River acquisition adds 2,000 boe/d, 50 net drilling locations, and 15 years of inventory, with 75% Tier 1 locations.
Pembina Cardium acquisition in 2025 was highly accretive, increasing production and reserves, and delivering $22 million in annual synergies.
Six strategic transactions in the past decade have grown production 11x and TPP reserves 14x.
Financial strength and capital allocation
Undrawn $190 million revolving credit facility and $16 million cash as of March 31, 2026; total borrowing base of $250 million.
Senior unsecured bond of $242 million at 6.23% due 2030, with a strong de-leveraging track record.
Capital allocation prioritizes debt reduction, base dividend (~$30 million/year), organic growth, acquisitions, and share repurchases.
FAFF yield of 20% and dividend coverage of 2.8x for 2026.
Latest events from InPlay Oil
- Record AFF, higher oil output, and a strategic acquisition drive upgraded 2026 outlook.IPO
Q2 2026 - Q2 delivered higher AFF, lower net debt, and a revised annual outlook amid operational delays.IPO
Q2 2024 - Production surged 125% post-acquisition, driving strong cash flow and accelerated debt reduction.IPO
Q2 2025 - Lower Q3 prices reduced AFF, but cost savings and strong wells support a positive Q4 outlook.IPO
Q3 2024 - 2024 delivered solid results and sets up transformational growth with the Pembina Cardium acquisition.IPO
Q4 2024 - Pembina acquisition drives record production, robust AFF, and higher 2025 guidance.IPO
Q1 2025 - Production and AFF surged in Q3 2025, prompting higher 2025 guidance and lower capital spending.IPO
Q3 2025 - Transformational acquisition fueled record production, reserves, and capital returns in 2025.IPO
Q4 2025 - Production and operating income surged over 100% year-over-year, with 2026 guidance raised.IPO
Q1 2026